Troy Rohn, a professor in the Department of Biological Sciences, in collaboration with San Diego biotech company Vala Sciences, co-authored an abstract which has been accepted by the Society for Neuroscience for presentation at its annual conference. The abstract pertains to the protein (ApoE4) that Rohn and his Boise State lab team have been studying for the past 10 years in order to understand how inheriting it enhances dementia risk at the molecular level.
The Society for Neuroscience conference is the largest in the world, with approximately 30,000 attendees. One of the 14,000 abstracts submitted, Rohn and Vala Sciences’ also was selected as a “Neuroscience 2019 Hot Topic,’ one of only about 100 abstracts to receive such status.
“We are excited to share these results with the scientific community involving our novel findings about ApoE4 in collaboration with Vala Sciences,” Rohn said. “This model system will enable us to test hundreds to thousands of compounds per week, to further define the mechanism via which ApoE4 may be causing dementia, and help us to identify drug candidates with potential therapeutic benefit against dementia.”
The abstract will be presented at the conference Oct. 19-23.
To learn more about Rohn and his team’s research on the ApoE4 protein, use the following link: https://www.ncbi.nlm.nih.gov/pubmed/31198491